Published in Transpl Int on September 29, 2014
Reduced exposure to calcineurin inhibitors in renal transplantation. N Engl J Med (2007) 9.44
Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med (2003) 8.47
Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence. Am J Transplant (2011) 4.06
Calcineurin inhibitor nephrotoxicity. Clin J Am Soc Nephrol (2009) 3.33
Diurnal variations of renal function in man. J Clin Invest (1950) 3.17
Identifying specific causes of kidney allograft loss. Am J Transplant (2008) 2.77
Calcineurin inhibitor minimization in the Symphony study: observational results 3 years after transplantation. Am J Transplant (2009) 1.88
OPTN/SRTR 2011 Annual Data Report: kidney. Am J Transplant (2013) 1.84
OPTN/SRTR 2011 Annual Data Report: liver. Am J Transplant (2013) 1.48
Chronic calcineurin inhibitor nephrotoxicity: reflections on an evolving paradigm. Clin J Am Soc Nephrol (2009) 1.27
Different effects of tacrolimus and cyclosporine on renal hemodynamics and blood pressure in healthy subjects. Transplantation (2002) 1.25
Improved adherence to tacrolimus once-daily formulation in renal recipients: a randomized controlled trial using electronic monitoring. Transplantation (2013) 1.16
Diurnal variations of glomerular filtration rate and albuminuria in diabetic nephropathy. Kidney Int (2002) 1.05
Once-daily extended-release versus twice-daily standard-release tacrolimus in kidney transplant recipients: a systematic review. Transplantation (2013) 1.05
Long-term graft survival with neoral and tacrolimus: a paired kidney analysis. J Am Soc Nephrol (2003) 1.03
A comparison of tacrolimus and cyclosporine in liver transplantation: effects on renal function and cardiovascular risk status. Am J Transplant (2005) 1.02
Efficacy and safety of conversion from twice-daily to once-daily tacrolimus in a large cohort of stable kidney transplant recipients. Am J Transplant (2011) 1.02
Two years postconversion from a prograf-based regimen to a once-daily tacrolimus extended-release formulation in stable kidney transplant recipients. Transplantation (2007) 1.01
Tacrolimus versus cyclosporin immunosuppression: long-term outcome in renal transplantation. Nephrol Dial Transplant (2003) 0.97
Interstitial fibrosis quantification in renal transplant recipients randomized to continue cyclosporine or convert to sirolimus. Am J Transplant (2009) 0.97
Endothelin mediates the renal vasoconstriction induced by cyclosporine in the rat. J Am Soc Nephrol (1990) 0.93
Circadian rhythms in systemic hemodynamics and renal function in healthy subjects and patients with nephrotic syndrome. Kidney Int (2001) 0.93
Cyclosporine nephrotoxicity in lung transplant recipients. Transplantation (1992) 0.93
Cyclosporine-associated end-stage nephropathy after cardiac transplantation: incidence and progression. Transplantation (1997) 0.91
Hyperfiltration and effect of nitric oxide inhibition on renal and endothelial function in humans with uncomplicated type 1 diabetes mellitus. Am J Physiol Regul Integr Comp Physiol (2012) 0.91
The effect of oral contraceptives on the nitric oxide system and renal function. Am J Physiol Renal Physiol (2007) 0.91
Cyclosporine A enhances renin secretion and production in isolated juxtaglomerular cells. Kidney Int (1988) 0.90
Renal hemodynamic effect of cyclooxygenase 2 inhibition in young men and women with uncomplicated type 1 diabetes mellitus. Am J Physiol Renal Physiol (2008) 0.90
Improvement of graft function after conversion to once daily tacrolimus of stable kidney transplant patients. Transplant Proc (2010) 0.89
Improved kidney graft function after conversion from twice daily tacrolimus to a once daily prolonged-release formulation. Transplant Proc (2011) 0.89
Nature and mediators of renal lesions in kidney transplant patients given cyclosporine for more than one year. Kidney Int (1999) 0.85
Conversion from twice-daily to once-daily Tacrolimus administration in liver transplant patient: results of long term follow-up. Eur Rev Med Pharmacol Sci (2013) 0.84
Renal hyperfiltration and systemic blood pressure in patients with uncomplicated type 1 diabetes mellitus. PLoS One (2013) 0.83
Conversion from twice-daily to once-daily tacrolimus in stable liver transplant patients: effectiveness in a real-world setting. Transplant Proc (2013) 0.83
Daily renal hypoperfusion induced by cyclosporine in patients with renal transplantation. Transplantation (1992) 0.82
Cyclosporine and the renin-angiotensin axis. Kidney Int (1997) 0.80
A prospective cohort conversion study of twice-daily to once-daily extended-release tacrolimus: role of ethnicity. Transplant Res (2014) 0.80
A comparison of short-term exposure of once-daily extended release tacrolimus and twice-daily cyclosporine on renal function in healthy volunteers. Transplantation (2010) 0.78
Renal dysfunction in liver transplantation: the problem and preventive strategies. Can J Gastroenterol (2004) 0.78
Cyclosporine increases endothelin-1 plasma levels in renal transplant recipients. Transplant Proc (2004) 0.76
Sustained vasoconstriction associated with daily cyclosporine dose in heart and lung transplant recipients: potential pathophysiologic role of endothelin. J Lab Clin Med (1995) 0.76
Renal hemodynamic effect of sodium-glucose cotransporter 2 inhibition in patients with type 1 diabetes mellitus. Circulation (2013) 3.53
Gender differences in the renal response to renin-angiotensin system blockade. J Am Soc Nephrol (2006) 1.91
Endothelial nitric oxide synthase gene polymorphisms and the renal hemodynamic response to L-arginine. Kidney Int (2008) 1.50
Impact of an exercise program on arterial stiffness and insulin resistance in hemodialysis patients. J Am Soc Nephrol (2004) 1.36
Vascular dysfunction in women with a history of preeclampsia and intrauterine growth restriction: insights into future vascular risk. Circulation (2010) 1.18
Effect of direct renin inhibition on renal hemodynamic function, arterial stiffness, and endothelial function in humans with uncomplicated type 1 diabetes: a pilot study. Diabetes Care (2009) 1.17
The effect of direct renin inhibition alone and in combination with ACE inhibition on endothelial function, arterial stiffness, and renal function in type 1 diabetes. Diabetes Care (2012) 0.92
Effect of protein kinase Cbeta inhibition on renal hemodynamic function and urinary biomarkers in humans with type 1 diabetes: a pilot study. Diabetes Care (2008) 0.91
Hyperfiltration and effect of nitric oxide inhibition on renal and endothelial function in humans with uncomplicated type 1 diabetes mellitus. Am J Physiol Regul Integr Comp Physiol (2012) 0.91
Age is a determinant of acute hemodynamic responses to hyperglycemia and angiotensin II in humans with uncomplicated type 1 diabetes mellitus. Am J Physiol Regul Integr Comp Physiol (2010) 0.90
Effects of oral contraceptive use on the renal and systemic vascular response to angiotensin II infusion. J Am Soc Nephrol (2004) 0.89
Long-term hemodynamic and molecular effects persist after discontinued renin-angiotensin system blockade in patients with type 1 diabetes mellitus. Kidney Int (2013) 0.88
Postpartum assessment of the renin angiotensin system in women with previous severe, early-onset preeclampsia. J Clin Endocrinol Metab (2011) 0.86
Renal hyperfiltration and arterial stiffness in humans with uncomplicated type 1 diabetes. Diabetes Care (2010) 0.85
Endothelial nitric oxide synthase gene/gender interactions and the renal hemodynamic response to angiotensin II. J Am Soc Nephrol (2005) 0.84
The angiotensin II receptor type 2 polymorphism influences haemodynamic function and circulating RAS mediators in normotensive humans. Nephrol Dial Transplant (2010) 0.83
Update on Estimation of Kidney Function in Diabetic Kidney Disease. Curr Diab Rep (2015) 0.82
Urinary ACE2 in healthy adults and patients with uncomplicated type 1 diabetes. Can J Physiol Pharmacol (2014) 0.78
Systemic hemodynamic function in humans with type 1 diabetes treated with protein kinase Cβ inhibition and renin-angiotensin system blockade: a pilot study. Can J Physiol Pharmacol (2011) 0.77
The effect of sex on humanin levels in healthy adults and patients with uncomplicated type 1 diabetes mellitus. Can J Physiol Pharmacol (2014) 0.76
Renal hemodynamic response to L-arginine in uncomplicated, type 1 diabetes mellitus: the role of buffering anions and tubuloglomerular feedback. Am J Physiol Renal Physiol (2012) 0.76
Chronotropic incompetence, impaired exercise capacity, and inflammation in recipients of continuous-flow left ventricular assist devices. J Heart Lung Transplant (2013) 0.76
Do effects of sodium-glucose cotransporter-2 inhibitors in patients with diabetes give insight into potential use in non-diabetic kidney disease? Curr Opin Nephrol Hypertens (2017) 0.75
Erratum. Dipeptidyl Peptidase 4 Inhibition Stimulates Distal Tubular Natriuresis and Increases in Circulating SDF-1α(1-67) in Patients With Type 2 Diabetes. Diabetes Care 2017;40:1073-1081. Diabetes Care (2017) 0.75
Nitric oxide-angiotensin II interactions and renal hemodynamic function in patients with uncomplicated type 1 diabetes. Am J Physiol Renal Physiol (2013) 0.75